$EWPI Is A School Yard Stock Pick !!!

On Friday $EWPI closed up 19.48% and The Dean just wouldn't be himself if he didn't point out the stocks 268% surge in trading volume to close out the week ( $EWPI traded 709,859 shares on Friday vs. an average 192,739 shares for the two weeks prior).



Emerging World Pharma Inc. is an investor in generic based pharmaceutical companies manufacturing within developing nations. Emerging World Pharma Inc. is unique in that it is focused on companies that assist developing nations to become self-sufficient in their medicine needs through the introduction of advanced production infrastructure, the hiring and training of local employees and the use of top quality raw materials.

The demand for medicine in developing nations is immense. Counterfeit medicines and unreliable medicine supply systems continue to impede access for these nations. Emerging World Pharma Inc. sees local pharmaceutical production as the future of the generic pharmaceutical industry because of the numerous benefits to both the pharmaceutical manufacturers and the nations that they operate in. The benefits of local production to the pharmaceutical manufacturing companies include: lowered production costs, reduced shipping demands and less stringent regulation. Some of the benefits of local production to the developing nations include: the reduction of foreign exchange costs, local job creation, promotion of social development and technology transfer facilitation.

In-depth market research is conducted to ensure that Emerging World Pharma Inc. invests in pharmaceutical companies that manufacture within nations that meet requirements of political and economic stability. Through this rigorous screening process and continual analysis of market viability, Emerging World Pharma Inc. is able to ensure a healthy return on investment.

Emerging World Pharma Inc.’s management team has international experience in growth-oriented technology, business unit development, finance, medicine and pharmaceutical manufacturing.

The global generic pharmaceutical industry is worth more than $40 billion and it is growing at an annual rate of 10-15%. Emerging World Pharma Inc. is one of few opportunities for investors to participate in this vast, recession-proof industry.

Emerging World Pharma Inc.’s strategic, in depth approach to investing in generic Pharma ensures that investments are made in the safest and most profitable emerging markets.